Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof - EP4084778

The patent EP4084778 was granted to Deciphera Pharmaceuticals on Nov 1, 2023. The application was originally filed on Dec 30, 2020 under application number EP20845854A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4084778

DECIPHERA PHARMACEUTICALS
Application Number
EP20845854A
Filing Date
Dec 30, 2020
Status
Granted And Under Opposition
Sep 29, 2023
Grant Date
Nov 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERAug 1, 2024HAMM & WITTKOPPADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS7780988
DESCRIPTIONUS8343550
DESCRIPTIONUS8461179
DESCRIPTIONUS8940756
INTERNATIONAL-SEARCH-REPORTUS8461179
INTERNATIONAL-SEARCH-REPORTWO2020185812
OPPOSITIONEP2858646
OPPOSITIONWO2016111725

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Dave A. Miller; Marco Gil , " Chapter 10 Spray-Drying Technology", Formulating Poorly Water-Soluble Drugs, Springer, (20111203), pages 363 - 442, doi:10.1007/978-1-4614-1144-4_10, XP009556892
OPPOSITION- Justin R. Hughey, Robert O. Williams III , "Chapter 3 Solid-State Techniques for Improving Solubility", Formulating Poorly Water-Soluble Drugs, Springer , (20111203), pages 95 - 131, doi:10.1007/978-1-4614-1144-4_3, ISBN 978-1-4614-1143-7, XP009556890
OPPOSITION- Navnit Shah, Harpreet Sandhu, Duk Soon Choi, Oskar Kalb, Susanne Page, Nicole Wyttenbach , "Chapter 8 Structured Development Approach for Amorphous Systems", Formulating Poorly Water-Soluble Drugs, Springer , (20111203), pages 267 - 310, doi:10.1007/978-1-4614-1144-4_8, ISBN 978-1-4614-1143-7, XP009556891
OPPOSITION- Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu, Anu Gupta, Cynthia B. Leary, Scott C. Wise, Thomas J. Rutkoski, Yu Mi Ahn, Gada Al-Ani, Stacie L. Bulfer, Timothy M. Caldwell, Lawrence Chun, Carol L. Ensinger, Molly M. Hood, Arin Mckinley, William C. Patt, Rodrigo Ruiz-Soto, Ying Su, Hanumaiah Telikepalli, Ajia Town, Benjamin A. Turner, Lakshminarayana Vogeti, Subha Vogeti, Karen Yates, Filip Janku, Albiruni Ryan Abdul Razak, Oliver Rosen, Michael C. Heinrich, Daniel L. Flynn, "Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants", CANCER CELL, CELL PRESS, US, US , (20190501), vol. 35, no. 5, doi:10.1016/j.ccell.2019.04.006, ISSN 1535-6108, pages 738 - 751.e9, XP055738739
OPPOSITION- Konno, H. ; Handa, T. ; Alonzo, D.E. ; Taylor, L.S., "Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20081001), vol. 70, no. 2, doi:10.1016/j.ejpb.2008.05.023, ISSN 0939-6411, pages 493 - 499, XP025470891
OPPOSITION- Miller Jonathan M., Beig Avital, Carr Robert A., Spence Julie K., Dahan Arik, "A Win-Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability", Molecular Pharmaceutics, American Chemical Society, US, US , (20120702), vol. 9, no. 7, doi:10.1021/mp300104s, ISSN 1543-8384, pages 2009 - 2016, XP055812634
OPPOSITION- Tanno Fumié; Nishiyama Yuichi; Kokubo Hiroyasu; Obara Sakaé, "Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.", Journal Drug Development and Industrial Pharmacy, NEW YORK, NY, US, US , (20040101), vol. 30, no. 1, doi:10.1081/DDC-120027506, ISSN 0363-9045, pages 9 - 17, XP009124621
OPPOSITION- Nemunaitis John, Bauer Sebastian, Blay Jean-Yves, Choucair Khalil, Gelderblom Hans, George Suzanne, Schöffski Patrick, Mehren Margaret Von, Zalcberg John, Achour Haroun, Ruiz-Soto Rodrigo, Heinrich Michael C, "Intrigue: Phase III Study of Ripretinib Versus Sunitinib in Advanced Gastrointestinal Stromal Tumor After Imatinib", FUTURE ONCOLOGY, FUTURE MEDICINE LTD., LONDON, GB, GB , (20200131), vol. 16, no. 1, doi:10.2217/fon-2019-0633, ISSN 1479-6694, pages 4251 - 4264, XP093202201
OPPOSITION- Dallas B. Warren, Benameur Hassan, Porter Christopher J.H., Pouton Colin W., "Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility", Journal of Drug Targeting, (20101201), vol. 18, no. 10, doi:10.3109/1061186X.2010.525652, ISSN 1061186X, pages 704 - 731, XP055027752

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents